★★★

MEDICOX

Shareholders' Meeting Called with FY2025 Net Loss of 11.85B Won, Accumulated Deficit of 67.3B Won


  • Consolidated net loss of 11.895 billion won (improved from 21.435 billion won prior year), loss before tax of 11.766 billion won.
  • Consolidated accumulated deficit of 67.299 billion won (similar to prior year).
  • No dividend: no dividends paid in last two fiscal years.
  • Consolidated total assets of 68.255 billion won, total liabilities of 21.146 billion won (assets down 13.4%, liabilities down 27.0% YoY).
  • Cash and cash equivalents of 377 million won (down 69.3% from 1.228 billion won prior year).
  • Short-term borrowings of 8.462 billion won (down 43.9% from 15.095 billion won prior year).
  • Outside director attendance: Lee Ki-yeon 100%, Kim Tae-ri 50%.
  • Proposals to approve director remuneration limit of 1.5 billion won and auditor remuneration limit of 100 million won.
  • Shareholders' meeting date: May 13, 2026, venue: Yeoksam Youth Center.

KOSDAQ Filing Information


  • Filing: Notice of Convocation of Shareholders' Meeting
  • Company: MEDICOX (054180)
  • Submission: MEDICOX Co., Ltd.
  • Receipt: 04-29-2026